Journal List > Asian Oncol Nurs > v.12(3) > 1081733

Lim, Lee, and Oh: Effectiveness of Physical Exercise in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Abstract

Purpose

To summarize and review the methodological quality of the evidence from trials examining the effectiveness of physical exercise in patients undergoing allogeneic hematopoietic stem cell transplantation (Allo-HSCT).

Methods

Six randomized clinical trials (RCTs) were identified, reviewed for substantive results, and assessed for methodological quality.

Results

Six trials met all methodological criteria on the modified Jadad score above 3 out of 5 points. Failure to blind the outcome assessor, and failure to describe the method of blinding of outcome assessor appropriately were the most prevalent methodological shortcomings. Various exercise modalities have been applied, differing in content, frequency, intensity, and duration. Positive results have been observed in part for a diverse set of outcomes, including physical and psychological performance.

Conclusion

The trials reviewed in this study were of moderate methodological quality. They suggest that exercise in patients undergoing Allo-HSCT may be safe and feasible, and in part patients benefit from increased physical performance both during and after transplantation. Future RCTs should use larger samples, appropriate comparison groups, and a standard of outcome measures, and examine what kind of exercise intervention (aerobic vs. resistance vs. combined) is the most effective for Allo-HSCT patients. It would be necessary to define contraindication for exercise to guarantee its safety.

Figures and Tables

Fig. 1
Flow diagram for trial identification and selection HSCT.
HSCT=hematopoietic stem cell transplantation.
aon-12-195-g001
Table 1
Methodological Quality Assessment for Each Included Study: Modified Jadad Scale
aon-12-195-i001

1) Was the study described as randomized (1=yes; 0=no)?, 2) Was the outcome assessment described as blinded (1=yes; 0=no)?, 3) Was there a description of withdrawals and dropouts (1=yes; 0=no)?, 4) Was the method of randomization well-described and appropriate (1=yes; 0=no)?, 5) Was the method of blinding of the assessment of outcomes well-described and appropriate (1=yes; 0=no)?, 6) Deduct 1 point if methods for randomization OR blinding were inappropriate.

Table 2
Randomized Controlled Trials in Patients undergoing Allogeneic Hematopoietic Transplantation
aon-12-195-i002

I=intervention group; C=control group; EORTC-QLQ-C30=European Organization for Research and Treatment of Cancer Quality of Life Questionnaire; FACT-An=Functional Assessment of Cancer therapy-Anemia scale; HADS=Hospital Anxiety and Depression Scale; 6MWT=6-minute walk test; MFI=Multidimensional Fatigue Index; POMS=Profile of Mood States; NCCN=National Comprehensive Cancer Network; TUDS=Timed Up and Down Stairs; TUG=Time Up and Go; 6 RM test=six repetition maximum; CHIP-CE/CRF=Child's Health and Illness Profile-Child Edition/Cancer Related Fatigue.

References

1. National Cancer Information Center. accessed on 30 April 2011. Available at: http://www.cancer.go.kr/cms/publicproject/education/index.html.
2. Korean National Statistical Office. Statistics for the Cause of Death on 2012.
3. Park HJ, Park EH, Jung KW, Kong HJ, Won YJ, Lee JY, et al. Statistics of hematologic malignancies in Korea: Incidence, prevalence and survival rates from 1999 to 2008. Korean J Hematol. 2012. 47:28–38.
4. Santos GW. Bone marrow transplantation in hematologic malignancies: Current status. Cancer. 1990. 65:786–791.
crossref
5. Kim MH. Main symptoms of cancer patients by stage in a general hospital [dissertation]. 2010. Seoul: Hanyang Univ..
6. Kim KS, Cho MY. Hematopoietic stem cell transplantation experiences in Korea. Proceedings of the 9th Annual Meeting of the Korean Society of Hematopoietic Stem Cell Transplantation. 2004. 2004 Aug 20-21; Busan, Korea. Seoul: Medrang.
7. Pallera AM, Schwartzberg LS. Managing the toxicity of hematopoietic stem cell transplant. J Support Oncol. 2004. 2:223.
8. Courneya KS, Keats MR, Turner AR. Physical exercise and quality of life in cancer patients following high dose chemotherapy and autologous bone marrow transplantation. Psychooncology. 2000. 9:127–136.
crossref
9. Danaher EH, Ferrans C, Verlen E, Ravandi F, van Besien K, Gelms J, et al. Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum. 2006. 33:614–624.
crossref
10. Schule K. The rank value of sports and movement therapy in patients with breast or pelvic cancer. Rehabilitation. 1983. 22:36–39.
11. Cunningham BA, Morris G, Cheney CL, Buergel N, Aker SN, Lenssen P. Effects of resistive exercise on skeletal muscle in marrow transplant recipients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1986. 10:558–563.
crossref
12. Mello M, Tanaka C, Dulley FL. Effects of an exercise program on muscle performance in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant. 2003. 32:723–728.
crossref
13. Jadad AR, Moore RA, Carrol D, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials. 1996. 17:1–12.
crossref
14. Jarden M, Baadsgaard MT, Hovgaard DJ, Boesen E, Adamsen L. A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant. 2009. 43:725–737.
crossref
15. Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Kleindienst N, et al. Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood. 2011. 117:2604–2613.
crossref
16. Shelton ML, Lee JQ, Morris GS, Massey PR, Kendall DG, Munsell MF, et al. A randomized control trial of a supervised versus a self-directed exercise program for allogeneic stemcell transplant patients. Psycho-Oncology. 2009. 18:353–359.
crossref
17. San Juan AF, Chamorro-Viña C, Moral S, Fernández del Valle M, Madero L, Ramírez M, et al. Benefits of intrahospital exercise training after pediatric bone marrow transplantation. Int J Sports Med. 2008. 29:439–446.
crossref
18. DeFor TE, Burns LJ, Gold EM, Weisdorf DJ. A Randomized trial of the effect of a walking regimen on the functional status of 100 adult allogeneic donor hematopoietic cell transplant patients. Biol Blood Marrow Transplant. 2007. 13:948–955.
crossref
19. Velthuis MJ, Agasi-Idenburg SC, Aufdemkampe G, Wittink HM. The effect of physical exercise on cancer-related fatigue during cancer treatment: a meta-analysis of random ised controlled trials. Clin Oncol (R Coll Radiol). 2010. 22:208–221.
crossref
20. Decker WA, Turner-McGlade J, Fehir KM. Psychosocial aspects and the physiological effects of a cardiopulmonary exercise program in patients undergoing bone marrow transplantation for acute leukemia. Transplant Proc. 1989. 21:3068–3069.
21. Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G. Physical exercise in cancer patients during and after medical treatment: A systematic review of randomized and controlled clinical trials. J Clin Oncol. 2005. 23:3830–3842.
crossref
22. Hayes SC, Spence RR, Galvao DA, Newton RU. Australian association for exercise and sport science position stand: optimising cancer outcomes through exercise. J Sci Med Sport. 2009. 12:428–434.
crossref
23. Szeluga DJ, Stuart RK, Brookmeyer R, Utermohlen V, Santos GW. Nutritional support of bone marrow parenteral nutrition to an enteral feeding program. Cancer Res. 1987. 47:3309–3316.
TOOLS
Similar articles